We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




High-Throughput Micro-Aperture Chip System Detects Cancer Cells

By LabMedica International staff writers
Posted on 24 Oct 2013
Print article
Image: Schematic depicting a new system that uses tiny magnetic beads to quickly detect rare types of cancer cells (Photo courtesy of Bin-Da Chan, Purdue School of Mechanical Engineering).
Image: Schematic depicting a new system that uses tiny magnetic beads to quickly detect rare types of cancer cells (Photo courtesy of Bin-Da Chan, Purdue School of Mechanical Engineering).
A system is being developed that uses tiny magnetic beads to quickly detect rare types of cancer cells circulating in a patient's blood.

The microchip system is based on a combination of immunomagnetic separation and microfluidics for high-throughput detection of whole cells and in this system target cells bound to magnetic beads flow parallel to a microchip.

Scientists at Purdue University (West Lafayette, IN, USA) combined the two techniques of immunomagnetic separation and microfluidics. In immunomagnetic separation, magnetic beads about a micron in diameter are "functionalized," or coated with antibodies that recognize and attach to antigens on the surface of target cells. The functionalized beads recognize breast cancer and lung cancer cells in laboratory cultures.

The updated design passes the fluid through a chamber that allows for faster flow; a standard 7.5 mL fluid sample can run through the system in a matter of minutes. The beads are directed by a magnetic field to a silicon mesh containing holes 8 µm in diameter. Because the target cells are so sparse, many of the beads fail to attract any and pass through the silicon mesh. The beads that have attached to cells are too large to pass through the holes in the mesh.

The cells can be analyzed clearly under a microscope and released from the chip for further analysis by removing the magnetic field. The system was characterized by detecting human breast adenocarcinoma cell line (MCF-7) and adenocarcinomic human alveolar basal epithelial cells (A549) in culture media using anti- epithelial cell adhesion molecule (EpCAM) conjugated magnetic beads.

Cagri A. Savran, PhD, an associate professor of Biomedical Engineering at Purdue, said, “We were able to detect cancer cells with up to a 90% yield. We expect this system to be useful in a wide variety of settings, including detection of rare cells for clinical applications. What's new here is that we've built a system that can perform all of these steps on one chip. It both separates cells and also places them on a chip surface so you can count them and study them with a microscope.” The study was highlighted on September 18, 2013, in the journal Lab on a Chip.

Related Links:

Purdue University


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultrasonic Cleaner
UC 300 Series
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.